Local Health Care Leaders Collaborate to Improve the Region

200 leaders, including two representatives from NOWDiagnostics, will come together to address challenges, economic and workforce development and community health.

SPRINGDALE, ARK. (April 6, 2016) – NOWDiagnostics Inc., based in Springdale, Ark., is sending two leaders to participate in the Northwest Arkansas Council’s inaugural Arkansas Health Care Summit.

Kevin Clark, Chief Executive Officer, and Jeff Ellis, Vice President of Sales and Marketing, will attend the event, along with leaders from Washington Regional Medical System, Northwest Health System, Mercy, the University of Arkansas for Medical Sciences and Arkansas Children’s Hospital. Clark and Ellis will participate in discussions to address challenges, economic and workforce development and community health.

WHEN:
Wednesday, April 6, 2016
8:30 a.m.: Hour long panel discussion
12:30 p.m.: Keynote speech by Jill Turner-Mitchael, Sam’s Club senior vice president for health and wellness

WHERE:
Embassy Suites, 3303 S. Pinnacle Hills Boulevard, Rogers, Ark.

BACKGROUND INFO:

The Greater Northwest Arkansas Development Strategy recommends growing the region’s health care economy. The goal of the Northwest Arkansas Health Care Summit is to build consensus around key priorities and initiatives.

Please note: The Northwest Arkansas Health Care Summit is an invitation-only event. Media representatives may attend two portions of the summit.

ABOUT NOWDIAGNOSTICS INC.

NOWDiagnostics Inc., based in Springdale, Ark., is a leader in innovative diagnostic health testing. As an Arkansas-based company, it is committed to improving the

Arkansas economy and is an integral part of a growing health care industry in the state. Its ADEXUSDx® product line features a lab at your fingertip, using only a drop of blood to test for a variety of conditions, illnesses and diseases with results in a matter of minutes. By eliminating the need to send tests to off-site laboratories, NOWDiagnostics has the potential to dramatically decrease the waiting period to determine test results.

The company is currently offering an hCG (pregnancy) test in the United States and Europe, and two cardiac (heart attack) tests and three toxicology tests in Europe. Additional tests are in the development pipeline, including sexually transmitted diseases, more cardiac (heart attack), food intolerances, common infectious diseases and a variety of screening tests.

For more information about NOWDiagnostics, visit www.nowdx.com.